MoonLake Immunotherapeutics Catapults On Rumored Merck Takeover

investors.com/news/technology/biotech-stock-moonlake-immunotherapeutics-takeover-merck

Biotech stock MoonLake Immunotherapeutics rocketed Tuesday on a report Merck offered to buy it for "more than $3 billion."
The post MoonLake Immunotherapeutics Catapults On Rumored Merck Takeover appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-06-03 13:27:21.
The Entire Business World on a Single Page. Free to Use →